Literature DB >> 12933852

Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.

Harry S Courtney1, David L Hasty, James B Dale.   

Abstract

Serum opacity factor (SOF) is a protein expressed by Streptococcus pyogenes that opacifies mammalian serum. SOF is also a virulence factor of S. pyogenes, but it has not been previously shown to elicit a protective immune response. Herein, we report that SOF evokes bactericidal antibodies against S. pyogenes in humans, rabbits, and mice. Rabbit antiserum against purified recombinant SOF2 opsonized SOF-positive M type 2, 4, and 28 S. pyogenes in human blood but had no effect on SOF-negative M type 5 S. pyogenes. Furthermore, affinity-purified human antibodies against SOF2 also opsonized SOF-positive streptococci. A combination of antisera against M2 and SOF2 proteins was dramatically more effective in killing streptococci than either antiserum alone, indicating that antibodies against SOF2 enhance the opsonic efficiency of M protein antibodies. Mice tolerated an intravenous injection of 100 microg of SOF without overt signs of toxicity, and immunization with SOF protected mice against challenge infections with M type 2 S. pyogenes. These data indicate that SOF evokes opsonic antibodies that may protect against infections by SOF-positive serotypes of group A streptococci and suggest that different serotypes of SOF have common epitopes that may be useful vaccine candidates to protect against group A streptococcal infections.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12933852      PMCID: PMC187301          DOI: 10.1128/IAI.71.9.5097-5103.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  emm and sof gene sequence variation in relation to serological typing of opacity-factor-positive group A streptococci.

Authors:  Bernard Beall; Giovanni Gherardi; Marguerite Lovgren; Richard R Facklam; Betty A Forwick; Gregory J Tyrrell
Journal:  Microbiology       Date:  2000-05       Impact factor: 2.777

2.  Recombinant, octavalent group A streptococcal M protein vaccine.

Authors:  J B Dale; M Simmons; E C Chiang; E Y Chiang
Journal:  Vaccine       Date:  1996-07       Impact factor: 3.641

3.  DNA sequence of the serum opacity factor of group A streptococci: identification of a fibronectin-binding repeat domain.

Authors:  J V Rakonjac; J C Robbins; V A Fischetti
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

4.  Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus.

Authors:  Y Ji; B Carlson; A Kondagunta; P P Cleary
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  Development of streptococcal pyrogenic exotoxin C vaccine toxoids that are protective in the rabbit model of toxic shock syndrome.

Authors:  J K McCormick; T J Tripp; S B Olmsted; Y V Matsuka; P J Gahr; D H Ohlendorf; P M Schlievert
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

6.  Group A streptococcus-liposome ELISA antibody titers to group A polysaccharide and opsonophagocytic capabilities of the antibodies.

Authors:  L G Salvadori; M S Blake; M McCarty; J Y Tai; J B Zabriskie
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

7.  Characterization of a novel fibronectin-binding surface protein in group A streptococci.

Authors:  B Kreikemeyer; S R Talay; G S Chhatwal
Journal:  Mol Microbiol       Date:  1995-07       Impact factor: 3.501

8.  Expression of the Arp protein, a member of the M protein family, is not sufficient to inhibit phagocytosis of Streptococcus pyogenes.

Authors:  L K Husmann; J R Scott; G Lindahl; L Stenberg
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

9.  Passive protection of mice against group A streptococcal pharyngeal infection by lipoteichoic acid.

Authors:  J B Dale; R W Baird; H S Courtney; D L Hasty; M S Bronze
Journal:  J Infect Dis       Date:  1994-02       Impact factor: 5.226

10.  Vaccination with streptococcal extracellular cysteine protease (interleukin-1 beta convertase) protects mice against challenge with heterologous group A streptococci.

Authors:  V Kapur; J T Maffei; R S Greer; L L Li; G J Adams; J M Musser
Journal:  Microb Pathog       Date:  1994-06       Impact factor: 3.738

View more
  19 in total

1.  Streptococcal protective antigens (Spa): a new family of type-specific proteins of group A streptococci.

Authors:  E A Ahmed; T A Penfound; S C Brewer; P A Tennant; E Y Chiang; J B Dale
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-10-29       Impact factor: 3.267

2.  Streptococcus pyogenes genes that promote pharyngitis in primates.

Authors:  Luchang Zhu; Randall J Olsen; Stephen B Beres; Matthew Ojeda Saavedra; Samantha L Kubiak; Concepcion C Cantu; Leslie Jenkins; Andrew S Waller; Zhizeng Sun; Timothy Palzkill; Adeline R Porter; Frank R DeLeo; James M Musser
Journal:  JCI Insight       Date:  2020-06-04

3.  Defense from the Group A Streptococcus by active and passive vaccination with the streptococcal hemoprotein receptor.

Authors:  Ya-Shu Huang; Morly Fisher; Ziyad Nasrawi; Zehava Eichenbaum
Journal:  J Infect Dis       Date:  2011-06-01       Impact factor: 5.226

4.  Intranasal vaccination with streptococcal fibronectin binding protein Sfb1 fails to prevent growth and dissemination of Streptococcus pyogenes in a murine skin infection model.

Authors:  J McArthur; E Medina; A Mueller; J Chin; B J Currie; K S Sriprakash; S R Talay; G S Chhatwal; M J Walker
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

Review 5.  Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections.

Authors:  Michael S Bronze; James B Dale
Journal:  Am J Med Sci       Date:  2010-09       Impact factor: 2.378

Review 6.  The structure and function of serum opacity factor: a unique streptococcal virulence determinant that targets high-density lipoproteins.

Authors:  Harry S Courtney; Henry J Pownall
Journal:  J Biomed Biotechnol       Date:  2010-07-08

7.  The group A streptococcal collagen-like protein-1, Scl1, mediates biofilm formation by targeting the extra domain A-containing variant of cellular fibronectin expressed in wounded tissue.

Authors:  Heaven Oliver-Kozup; Karen H Martin; Diane Schwegler-Berry; Brett J Green; Courtney Betts; Arti V Shinde; Livingston Van De Water; Slawomir Lukomski
Journal:  Mol Microbiol       Date:  2012-12-26       Impact factor: 3.501

8.  Function of the fibronectin-binding serum opacity factor of Streptococcus pyogenes in adherence to epithelial cells.

Authors:  Sonja Oehmcke; Andreas Podbielski; Bernd Kreikemeyer
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

Review 9.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

10.  Detecting key structural features within highly recombined genes.

Authors:  John E Wertz; Karen F McGregor; Debra E Bessen
Journal:  PLoS Comput Biol       Date:  2007-01-26       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.